Genpharmasec Limited (BOM:531592)
1.080
0.00 (0.00%)
At close: Nov 17, 2026
Genpharmasec Revenue
Genpharmasec had revenue of 856.58M INR in the quarter ending September 30, 2026, with 162.46% growth. This brings the company's total for the last twelve months to 2.31B, up 243.32% year-over-year. In the fiscal year ending March 31, 2026, Genpharmasec had annual revenue of 1.40B with 314.98% growth. That makes Genpharmasec the 32,668th largest company in the world by revenue and 2,473rd in India.
Revenue (ttm)
2.31B
Revenue Growth
+243.32%
P/S Ratio
0.26
Revenue / Employee
177.40M
Employees
13
Market Cap
598.02M
Revenue by Segment
- Pharmaceuticals 1.31B 93.5%
- Manufacturing & Processing 80.62M 5.8%
- Laboratory Testing 10.05M 0.7%
Fiscal year ended Mar 31, 2026 See the full Genpharmasec breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.40B | 1.06B | 314.98% |
| Mar 31, 2025 | 337.22M | 33.16M | 10.91% |
| Mar 31, 2024 | 304.06M | 48.90M | 19.16% |
| Mar 31, 2023 | 255.16M | -18.05M | -6.61% |
| Mar 31, 2022 | 273.21M | 60.13M | 28.22% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AVI Polymers | 3.86B |
| MetroGlobal | 2.49B |
| Aureate Tradde | 1.82B |
| Yash Chemex | 1.32B |
| Dhoot Industrial Finance | 1.01B |
| Laffans Petrochemicals | 78.31M |
| Roni Households | 20.41M |
| IEL Limited | 14.70M |